Wealth Advisory Team LLC bought a new stake in Procter & Gamble Company (The) (NYSE:PG – Free Report) during the 2nd quarter, HoldingsChannel reports. The fund bought 5,737 shares of the company’s stock, valued at approximately $914,000. Procter & Gamble comprises 0.9% of Wealth Advisory Team LLC’s portfolio, making the stock its 20th biggest position.
Other large investors have also recently added to or reduced their stakes in the company. Benjamin Edwards Inc. increased its position in Procter & Gamble by 120.7% in the 1st quarter. Benjamin Edwards Inc. now owns 364,378 shares of the company’s stock valued at $62,098,000 after acquiring an additional 199,258 shares during the period. Capital Investment Advisory Services LLC boosted its stake in Procter & Gamble by 13.8% during the 1st quarter. Capital Investment Advisory Services LLC now owns 37,709 shares of the company’s stock valued at $6,426,000 after purchasing an additional 4,562 shares in the last quarter. World Investment Advisors boosted its stake in Procter & Gamble by 6.0% during the 1st quarter. World Investment Advisors now owns 50,913 shares of the company’s stock valued at $8,677,000 after purchasing an additional 2,886 shares in the last quarter. Concurrent Investment Advisors LLC boosted its stake in Procter & Gamble by 26.4% during the 1st quarter. Concurrent Investment Advisors LLC now owns 120,002 shares of the company’s stock valued at $20,451,000 after purchasing an additional 25,059 shares in the last quarter. Finally, Diversify Wealth Management LLC boosted its stake in Procter & Gamble by 10.3% during the 1st quarter. Diversify Wealth Management LLC now owns 23,719 shares of the company’s stock valued at $3,849,000 after purchasing an additional 2,210 shares in the last quarter. 65.77% of the stock is currently owned by institutional investors and hedge funds.
Procter & Gamble Stock Performance
PG opened at $149.69 on Friday. The firm has a market cap of $350.34 billion, a PE ratio of 22.99, a P/E/G ratio of 3.97 and a beta of 0.36. The company has a quick ratio of 0.49, a current ratio of 0.70 and a debt-to-equity ratio of 0.49. The business has a fifty day simple moving average of $155.24 and a 200-day simple moving average of $159.48. Procter & Gamble Company has a fifty-two week low of $149.45 and a fifty-two week high of $180.43.
Insider Buying and Selling
In other news, insider Balaji Purushothaman sold 490 shares of the stock in a transaction on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total value of $74,592.70. Following the completion of the sale, the insider owned 12,616 shares in the company, valued at $1,920,533.68. This represents a 3.74% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, COO Shailesh Jejurikar sold 3,986 shares of the stock in a transaction on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total value of $606,788.78. Following the completion of the sale, the chief operating officer owned 46,899 shares of the company’s stock, valued at $7,139,434.77. The trade was a 7.83% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 149,763 shares of company stock valued at $23,421,279. 0.20% of the stock is currently owned by company insiders.
Analysts Set New Price Targets
A number of brokerages have issued reports on PG. Wells Fargo & Company decreased their price target on Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating for the company in a research note on Thursday, September 25th. BNP Paribas Exane decreased their price target on Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating for the company in a research note on Tuesday, September 23rd. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Procter & Gamble in a research note on Wednesday. Bank of America decreased their price target on Procter & Gamble from $180.00 to $174.00 and set a “buy” rating for the company in a research note on Wednesday. Finally, JPMorgan Chase & Co. reduced their price objective on Procter & Gamble from $170.00 to $163.00 and set a “neutral” rating for the company in a research note on Friday. Eleven investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $172.21.
View Our Latest Analysis on PG
About Procter & Gamble
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Further Reading
- Five stocks we like better than Procter & Gamble
- Why is the Ex-Dividend Date Significant to Investors?
- Bassett Furniture: Buy Now, Sit Back, and Collect Dividends
- How to Invest in Tech StocksĀ and Top Tech Stocks to Consider
- AST SpaceMobile’s Big Win: Shares Soar on New Deal With Verizon
- Using the MarketBeat Dividend Tax Calculator
- Catch the Next Bitcoin Rally With These 3 ETFs
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.